Faeth Therapeutics Inc. logo

Faeth Therapeutics Inc.

FTH | NASDAQ
Chart Builder DCF Calculator
$18.69
-$0.06 (-0.32%)
At close: Oct 30, 2026, 4:00 PM ET
$18.32
-$0.37 (-1.98%)
After-hours: Oct 30, 2026, 7:30 PM ET
Fiscal Quarter
Period Ending
Q2 2026
Jun 30, 2026
Q1 2026
Mar 31, 2026
Q4 2025
Dec 31, 2025
Q3 2025
Sep 30, 2025
Q2 2025
Jun 30, 2025
Q1 2025
Mar 31, 2025
Q4 2024
Dec 31, 2024
Q3 2024
Sep 30, 2024
Q2 2024
Jun 30, 2024
Q1 2024
Mar 31, 2024
Q4 2023
Dec 31, 2023
Q3 2023
Sep 30, 2023
Q2 2023
Jun 30, 2023
Q1 2023
Mar 31, 2023
Q4 2022
Dec 31, 2022
Q3 2022
Sep 30, 2022
Q2 2022
Jun 30, 2022
Q1 2022
Mar 31, 2022
Q4 2021
Dec 31, 2021
Q3 2021
Sep 30, 2021
Q2 2021
Jun 30, 2021
Q1 2021
Mar 31, 2021
Revenue
n/a n/a n/a -4.85M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a 132.96M n/a -4.85M n/a n/a 139K 140K 135K 137K 135K 455K 491K n/a 469K 451K 440K 448K 329K 136K 122K 98K
Gross Profit
n/a -132.96M n/a n/a n/a n/a -139K -140K -135K -137K -135K -455K -491K n/a -469K -451K -440K -448K -329K -136K -122K -98K
Operating Income
-18.39M -170.63M -4.96M -4.85M -5.21M -7.27M -7.32M -7.82M -7.79M -8.73M -8.14M -7.74M -10.19M -11.01M -11.98M -13.94M -10.71M -12.49M -9.41M -10.32M -9.78M -7.97M
Interest Income
2.26M 392K 223K 289K 321K 405K 522K 591K 669K 768K 826K 877K 952K 969K 609K 515K 349K 310K 334K 278K 188K n/a
Pretax Income
-16.01M -170.24M -4.72M -4.57M -4.94M -6.86M -7.77M -7.25M -7.14M -7.99M -7.41M -7.12M -9.39M -10.18M -12.23M -13.42M -10.54M -12.41M -9.37M -9.69M -9.77M -7.97M
Net Income
-16.01M -170.24M -4.72M -4.57M -4.94M -6.86M -7.77M -7.25M -7.14M -7.99M -7.41M -7.12M -9.39M -10.18M -12.23M -13.42M -10.54M -12.41M -9.37M -9.69M -9.77M -7.97M
Selling & General & Admin
9.21M 19.71M 2.79M 2.32M 2.67M 3.55M 2.7M 3.05M 3.07M 3.68M 3.51M 3.46M 5.21M 5.8M 4.97M 4.3M 3.88M 4.58M 3.13M 3.74M 3.76M 4.51M
Research & Development
9.18M 17.96M 2.17M 2.54M 2.53M 3.73M 4.49M 4.64M 4.58M 4.92M 4.49M 3.82M 4.48M 5.2M 6.55M 9.19M 6.39M 7.46M 5.96M 6.44M 5.9M 3.37M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
18.39M 37.67M 4.96M 4.85M 5.21M 7.27M 7.18M 7.68M 7.65M 8.59M 8.01M 7.28M 9.69M 11.01M 11.51M 13.49M 10.27M 12.04M 9.08M 10.18M 9.66M 7.87M
Interest Expense
n/a n/a 3K 6K 10K 13K 17K 21K 24K 28K 31K 33K 38K 42K n/a 10K 172K 243K 306K 214K 147K 3K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a -137K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
18.39M 170.63M 4.96M n/a 5.21M 7.27M 7.32M 7.82M 7.79M 8.73M 8.14M 7.74M 10.19M 11.01M 11.98M 13.94M 10.71M 12.49M 9.41M 10.32M 9.78M 7.97M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
5.64M 1.3M 1.26M 1.26M 1.26M 1.26M 1.26M 1.26M 1.26M 1.25M 1.25M 1.28M 1.53M 1.54M 1.54M 1.54M 1.54M 1.53M 1.53M 1.53M 1.53M 1.53M
Shares Outstanding (Diluted)
5.64M 1.3M 1.26M 1.26M 1.26M 1.26M 1.26M 1.26M 1.26M 1.25M 1.25M 1.28M 1.53M 1.54M 1.54M 1.54M 1.54M 1.53M 1.53M 1.53M 1.53M 1.53M
EPS (Basic)
-2.84 -131.45 -3.74 -3.62 -3.91 -5.45 -6.18 -5.77 -5.69 -6.38 -5.92 -5.58 -6.15 -6.59 -7.96 -8.73 -6.86 -8.10 -6.12 -6.33 -6.39 -5.21
EPS (Diluted)
-2.84 -131.45 -3.74 -3.62 -3.91 -5.45 -6.18 -5.77 -5.69 -6.38 -5.92 -5.58 -6.15 -6.59 -7.96 -8.73 -6.86 -8.10 -6.12 -6.33 -6.39 -5.21
EBITDA
-15.98M -170.21M -4.68M -4.53M -4.89M -6.82M -7.61M -7.09M -6.98M -7.83M -7.25M -6.64M -8.86M -9.78M -11.76M -12.96M -9.92M -11.71M -8.73M -9.34M -9.5M -7.87M
EBIT
-16.01M -170.24M -4.71M -4.56M -4.93M -6.85M -7.75M -7.23M -7.12M -7.96M -7.38M -7.09M -9.35M -10.14M -12.23M -13.41M -10.36M -12.16M -9.06M -9.47M -9.62M -7.97M
Depreciation & Amortization
25K 30K 34K 34K 37K 34K 139K 140K 135K 137K 135K 455K 491K 358K 469K 451K 440K 448K 329K 136K 122K 98K

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.